A post-thoracentesis chest x-ray showed re-expansion of the right lung with stable bibasilar opacities and minimal blunting of the right costophrenic angle. Notably, there was a small right apical pneumothorax (figure 2).

Figure 2: chest x-rays pre- and post-thoracentesis illustrating resolution of pleural effusion: the pre-thoracentesis chest x-ray (a) shows a large right pleural effusion with associated near-complete collapse of the right lung and leftward mediastinal shift. The post-thoracentesis chest x-ray (b) demonstrates the re-expansion of the right lung, with resolution of the effusion and minimal residual blunting of the right costophrenic angle. A small right apical pneumothorax is also observed.

Discussion
This case of a large right-sided pleural effusion secondary to cirrhosis in the absence of significant ascites is particularly noteworthy due to its atypical presentation. Commonly, hepatic hydrothorax is associated with significant ascitic fluid; however, in this instance, the patient’s presentation with a large pleural effusion without corresponding ascites necessitated a thorough diagnostic approach. The use of light's criteria was instrumental in categorizing the effusion as transudative, consistent with hepatic hydrothorax rather than other etiologies such as exudative effusions, which might indicate malignancy or infection.

Pathophysiology and alternative mechanisms
The pathophysiology underlying hepatic hydrothorax in the absence of ascites remains complex and multifactorial. Several mechanisms potentially contribute to the formation of pleural effusion without significant ascitic fluid:

Increased hydrostatic pressure: portal hypertension, a relatively common complication of cirrhosis, leads to elevated pressures within the splanchnic circulatory network. This elevated hydrostatic pressure can extend to the pleural capillaries, promoting the transudation of fluid into the pleural space⁷. Normally, this fluid accumulates in the peritoneal cavity as ascites, but in some cases, it may preferentially migrate into the pleural space through microscopic diaphragmatic defects or via direct transudation due to localized pressure gradients.

Decreased oncotic pressure: hypoalbuminemia, frequently seen in patients with advanced liver disease, reduces plasma oncotic pressure, facilitating fluid movement from the intravascular compartment to the extravascular space. Albumin, a major plasma protein synthesized by the liver, plays a crucial role in maintaining colloid osmotic pressure. In cirrhosis, hypoalbuminemia results from impaired hepatic synthesis and increased capillary permeability, contributing to fluid accumulation in body cavities, including the pleural space⁸.

Diaphragmatic defects: small, often microscopic, defects in the tendinous portion of the diaphragm can act as conduits for fluid passage from the peritoneal cavity to the pleural space. These defects may be congenital or acquired, possibly exacerbated by increased intra-abdominal pressure due to portal hypertension. The negative intrathoracic pressure generated during respiration further facilitates this fluid migration. This mechanism, although typically associated with the presence of ascites, can occur independently, leading to isolated pleural effusions. A similar presentation of a pleural effusion in the absence of abdominal ascites was noted in a case, in which, two patients who presented with right-sided pleural effusions and no abdominal ascites. Both patients had diaphragmatic defects: one was an old traumatic diaphragmatic tear and the other a pinpoint spontaneous perforation⁹. Another case describing a difficult diagnostic and therapeutic management of a massive pleural effusion on the right side in the absence of any relevant ascites mentions the likely direct movement of fluid from the peritoneal cavity into the pleural space through diaphragmatic defects¹⁰.

Lymphatic obstruction: impaired lymphatic drainage due to cirrhosis and portal hypertension can contribute to pleural effusion formation. The thoracic duct, responsible for draining lymph from the abdomen into the venous system, may be compromised by elevated pressures, leading to lymphatic overflow and subsequent transudation of fluid into the pleural cavity¹¹. This lymphatic dysfunction is compounded by the systemic effects of cirrhosis, including hypoalbuminemia and altered vascular permeability.

Clinical implications and diagnostic approach
The unusual presentation of hepatic hydrothorax without ascites poses a diagnostic challenge. This case underscores the importance of maintaining a high index of suspicion in cirrhotic patients presenting with respiratory symptoms. Comprehensive diagnostic evaluation is essential and should include:

Imaging studies: chest radiography and computed tomography (ct) scans are pivotal in identifying pleural effusions and assessing the extent of lung involvement. In this case, imaging revealed a significant right-sided pleural effusion with near-total lung collapse and mediastinal shift, underscoring the severity of the presentation. Ct angiography additionally confirmed liver morphology consistent with cirrhosis and excluded pulmonary embolism.

Pleural fluid analysis: thoracentesis and subsequent analysis of pleural fluid are critical in differentiating transudative from exudative effusions. Light's criteria, based on pleural fluid protein and lactate dehydrogenase (ldh) levels relative to serum values, classify the effusion as transudative in this case. This classification is consistent with hepatic hydrothorax and helps exclude other etiologies such as malignancy, infection, or inflammatory conditions.

Laboratory investigations: evaluating liver function tests, coagulation profiles, and renal function is vital in understanding the overall impact of cirrhosis and guiding therapeutic interventions. In this case, significant hepatic dysfunction, including hyperbilirubinemia, hypoalbuminemia, elevated liver enzymes, and coagulopathy, was evident. Additionally, renal impairment and electrolyte imbalances were noted, reflecting the systemic effects of advanced liver disease.

Management strategies
Managing hepatic hydrothorax, especially in the absence of ascites, requires a multifaceted approach:

Thoracentesis: this procedure serves as a critical intervention to alleviate symptoms and improve respiratory function¹². In this patient, successful drainage of pleural fluid and subsequent lung re-expansion underscored the effectiveness of thoracentesis. Regular monitoring and repeat thoracentesis may be necessary to manage recurrent effusions. Complications such as pneumothorax, as observed in this case, highlight the need for careful technique and post-procedural monitoring.

Diuretics: diuretics, including spironolactone and furosemide, can help manage fluid overload and reduce the recurrence of effusions. Their use must be balanced against the risk of renal impairment, which is often present in cirrhotic patients. Careful titration and monitoring of renal function and electrolytes are essential to optimize diuretic therapy. Additionally, sodium restriction may enhance the efficacy of diuretics in controlling fluid balance.

Transjugular intrahepatic portosystemic shunt (tips): for patients with refractory hepatic hydrothorax, tips can reduce portal hypertension and decrease fluid transudation into the pleural space. This procedure involves creating a shunt between the portal and systemic venous circulation, thereby alleviating portal pressure. Tips has shown efficacy in managing recurrent pleural effusions, although it carries risks such as hepatic encephalopathy and requires careful patient selection¹³.

Liver transplantation: in cases of advanced liver disease, liver transplantation remains the definitive treatment. This option should be considered in patients with severe hepatic dysfunction and refractory hydrothorax, as it addresses the underlying cause and improves long-term outcomes. Pre-transplant evaluation and optimization of the patient’s clinical status are crucial to enhance post-transplant prognosis.

Conclusion
This case underscores the clinical significance of recognizing atypical presentations of pleural effusion in patients with cirrhosis. It emphasizes the necessity for thorough diagnostic evaluations, including advanced imaging and pleural fluid analysis using light's criteria, to understand the complex interplay of factors contributing to pleural effusion in the absence of ascites. The successful resolution of the effusion through thoracentesis illustrates the effectiveness of appropriate intervention. However, it also calls for ongoing research into the pathophysiology of such presentations and potential preventive strategies to mitigate the risk of recurrence or complications. An enhanced understanding of these mechanisms could lead to improved patient outcomes and guide the development of targeted therapeutic approaches in cirrhosis-associated pleural effusions. 

References   
1. chaaban t, kanj n, bou akl i. Hepatic hydrothorax: an updated review on a challenging disease. Lung 2019;197:399-405.
2. pippard b, bhatnagar m, mcneill l, donnelly m, frew k, aujayeb a. Hepatic hydrothorax: a narrative review. Pulm ther 2022;8:241-254.
3. kamath s, sunder a. Hepatic hydrothorax in the absence of ascites: a diagnostic challenge. Cureus 2021;13:16650.
4. soeters pb, wolfe rr, shenkin a. Hypoalbuminemia: pathogenesis and clinical significance. Jpen j parenter enteral nutr 2019;43(2):181-193.
5. wilkins h, britt e, bhatnagar m, pippard b. Hepatic hydrothorax. J thorac dis 2024;16(2):1662-1673.
6. light rw. The light criteria: the beginning and why they are useful 40 years later. Clin chest med 2013;34:21-26.
7. iwakiri y. Pathophysiology of portal hypertension. Clin liver dis 2014;18:281-291.
8. kim js, kim cw, nam hs, cho jh, ryu js, lee hl. Hepatic hydrothorax without ascites as the first sign of liver cirrhosis. Respirol case rep 2015;4(1):16-18.
9. hartz rs, bomalaski j, locicero j, murphy rl. Pleural ascites without abdominal fluid: surgical considerations. J thorac cardiovasc surg 1984;87:141-143.
10. von bierbrauer a, dilger m, weissenbach p, walle j. Hepatic hydrothorax--a rare cause of pleural effusion that is difficult to manage. Pneumologie 2008;62(1):40-43.
11. kumar r, anand u, priyadarshi rn. Lymphatic dysfunction in advanced cirrhosis: contextual perspective and clinical implications. World j hepatol 2021;13(3):300-314.
12. singh a, bajwa a, shujaat a. Evidence-based review of the management of hepatic hydrothorax. Respiration 2013;86(2):155-73.
13. copelan a, kapoor b, sands m. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin intervent radiol 2014;31(3):235-242.